雅虎香港 搜尋

登入

搜尋結果

  1. www.ema.europa.eu › en › documentsINTANZA, INN-Influenza vaccine (split virion, inactivated) - ...

    INTANZA is at least as immunogenic as the comparator trivalent inactivated influenza vaccine administered by intramuscular route for each of the 3 influenza strains in subjects from 60 years of age and over.

    • 1MB
    • 27

  2. www.tandfonline.com › doi › pdfIntanza ® 9 µg intradermal seasonal influenza ...

    Intanza® 9 μg is considered satisfactory by at least 95% of both vaccinees and prescribers, especially because of the short needle and rapid administration. Because Intanza® 9 μg ofers an alternative to intramuscular vaccines, it might help increase influenza vaccine coverage rates.

  3. 其他人也問了

  4. www.ema.europa.eu › en › medicinesIntanza | European Medicines Agency

    Intanza. Active substance. influenza virus (inactivated, split) of the following strains:A/California/7/2009 (H1N1)pdm09 - like strain (A/California/7/2009, NYMC X-179A)A/Hong Kong/4801/2014 (H3N2) - like strain (A/Hong Kong/4801/2014, NYMC X-263B)B/Brisbane/60/2008 - like strain (B/Brisbane/60/2008, wild type) International non-proprietary ...

  5. pubmed.ncbi.nlm.nih.gov › 21105776Intanza(®): a new intradermal vaccine for seasonal influenza

    Seasonal influenza causes annual epidemics in temperate climates and is associated with economic costs, morbidity and mortality. Vaccination is the primary method of prevention. Intanza (®) (Sanofi Pasteur, Lyon, France) is a newly licensed, trivalent, inactivated influenza vaccine that is delivered ….

    • Robert L Atmar, Shital M Patel, Wendy A Keitel
    • 2010

  6. europepmc.org › article › MEDIntanza (®) 9 µg intradermal seasonal influenza ...

    2013年1月1日 · Intanza 9 µg is considered satisfactory by at least 95% of both vaccinees and prescribers, especially because of the short needle and rapid administration. Because Intanza® 9 µg offers an alternative to intramuscular vaccines, it might help increase influenza vaccine coverage rates.

    • Isabel Leroux-Roels, Françoise Weber
    • 2013

  7. www.tandfonline.com › doi › fullIntanza®: a new intradermal vaccine for seasonal ...

    2014年1月9日 · Intanza ® (Sanofi Pasteur, Lyon, France) is a newly licensed, trivalent, inactivated influenza vaccine that is delivered intradermally with a proprietary micoinjection system. Two dosage formulations have been approved for use in Europe and Australia.

  8. www.ema.europa.eu › en › documentsIntanza; common name: influenza vaccine (split virion, ...

    Intanza is used to vaccinate adults aged 60 years and over against flu, especially those who are at an increased risk of developing complications from the disease. The use of the vaccine should be based on